Meta-Analysis of Multiple Primary Prevention Trials of Cardiovascular Events Using Aspirin
- 11 April 2011
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 107 (12) , 1796-1801
- https://doi.org/10.1016/j.amjcard.2011.02.325
Abstract
No abstract availableKeywords
Funding Information
- Bayer HealthCare
This publication has 12 references indexed in Scilit:
- Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial IndexA Randomized Controlled TrialJAMA, 2010
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled TrialJAMA, 2008
- The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial diseaseBMJ, 2008
- Meta-Analysis of Data from the Six Primary Prevention Trials of Cardiovascular Events Using AspirinThe American Journal of Cardiology, 2006
- A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpointsStatistics in Medicine, 2005
- Inflation of type I error rate in two statistical tests for the detection of publication bias in meta‐analyses with binary outcomesStatistics in Medicine, 2002
- Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and RationaleAnnals of Internal Medicine, 2002
- Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysisBMJ, 2001
- A comparison of methods to detect publication bias in meta‐analysisStatistics in Medicine, 2001